BCAL Diagnostics (ASX:BDX) Dividend Yield % : 0.00% (As of Jun. 01, 2024)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Dividend Yield %?

As of today (2024-06-01), the Trailing Annual Dividend Yield of BCAL Diagnostics is 0.00%.

The historical rank and industry rank for BCAL Diagnostics's Dividend Yield % or its related term are showing as below:

ASX:BDX's Dividend Yield % is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 2.01
* Ranked among companies with meaningful Dividend Yield % only.

BCAL Diagnostics's Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00.

As of today (2024-06-01), the Forward Dividend Yield % of BCAL Diagnostics is 0.00%.

BCAL Diagnostics's Dividends per Share for the six months ended in Dec. 2023 was A$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

BCAL Diagnostics Dividend Yield % Historical Data

The historical data trend for BCAL Diagnostics's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Dividend Yield % Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

Dividend Yield %

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Dividend Yield %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of BCAL Diagnostics's Dividend Yield %

For the Diagnostics & Research subindustry, BCAL Diagnostics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BCAL Diagnostics's Dividend Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BCAL Diagnostics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where BCAL Diagnostics's Dividend Yield % falls into.

BCAL Diagnostics Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

BCAL Diagnostics (ASX:BDX) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

BCAL Diagnostics Dividend Yield % Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.